Browsing Technical documents and research evidence on COVID-19 by Title
Now showing items 1333-1352 of 1749
-
Respiratory conditions in coronavirus disease 2019 (COVID-19): Important considerations regarding novel treatment strategies to reduce mortality
(2020-04-22)A novel virus named 2019 novel coronavirus (2019-nCoV/SARS-CoV-2) causes symptoms that are classified as coronavirus disease (COVID-19). Respiratory conditions are extensively described among more serious cases of COVID-19, ... -
Respiratory Syndrome Coronavirus Infections: Possible Mechanisms of Neurological Implications—A Systematic Review
(2020-08-21)Within the context of the worst pandemic of the century—Covid-19—which emerged in China and has spread across the entire globe over the last 6 months, increased knowledge about viral behavior that be prognostic is crucial. ... -
Respiratory virus shedding in exhaled breath and efficacy of face masks
(2020-04-03)[Abstract]. We identified seasonal human coronaviruses, influenza viruses and rhinoviruses in exhaled breath and coughs of children and adults with acute respiratory illness. Surgical face masks significantly reduced ... -
Responding to community spread of COVID-19 7, Interin Guidance, 7 March 2020
This document provides guidance for responding to community transmission of COVID-19. -
Retraction and republication: cardiac toxicity of hydroxychloroquine in COVID-19
(2020-07-09)A recent Lancet Article by Mandeep Mehra and colleagues, which reported adverse events associated with hydroxychloroquine or chloroquine treatment in patients with COVID-19, has been retracted by three of the authors, along ... -
Retrofit Measures for COVID-19, 10 June 2020
(2020-06-16)PAHO Smart Hospitals Project started in 2009 and has been implemented across nine countries in the Caribbean Region. The onset of the COVID-19 pandemic has introduced new lessons to be incorporated as part of Smart Retrofits. ... -
Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: an in silico study
(2020-04-15)At present, novel Coronavirus (2019-nCoV, the causative agent of COVID-19) has caused worldwide social and economic disruption. The disturbing statistics of this infection promoted us to develop an effective vaccine candidate ... -
Review of Current Evidence of Hydroxychloroquine in Pharmacotherapy of COVID-19
(2020-05-13)Importance: The COVID-19 Pandemic has literally left the world breathless in the chase for pharmacotherapy. With vaccine and novel drug development in early clinical trials, repurposing of existing drugs takes the center ... -
A Review of SARS-CoV-2 and the Ongoing Clinical Trials
(2020-04-10)The sudden outbreak of 2019 novel coronavirus (2019-nCoV, later named SARS-CoV-2) in Wuhan, China, which rapidly grew into a global pandemic, marked the third introduction of a virulent coronavirus into the human society, ... -
Revision to CDC’s Zika Travel Notices: Minimal Likelihood for Mosquito-Borne Zika Virus Transmission at Elevations Above 2,000 Meters
(2016-06)Since May 2015, when Zika virus, a flavivirus transmitted primarily by Aedes aegypti mosquitoes, was reported in Brazil, the virus has rapidly spread across the Region of the Americas and the Caribbean. The association ... -
A rhesus macaque model of Asian-lineage Zika virus infection
(2016-06)Infection with Asian-lineage Zika virus (ZIKV) has been associated with Guillain–Barré syndrome and fetal abnormalities, but the underlying mechanisms remain poorly understood. Animal models of infection are thus urgently ... -
Ribavirin was beneficial for patients with SARS and MERS: uncertain if it is effective for patients with COVID-19
(2020-03-20)Citation: Luo T, Na Y, Tan L, et al. The Possibility of Ribavirin in the Treatment of the Coronavirus Disease 2019: A Systematic Review. China Pharmaceuticals 2020; 29(5): 34-9 Language: Chinese What is this? Like COVID-19, ... -
Risk assessment for yellow fever in western and North-Western provinces of Zambia
(2015)Background: North-Western and Western provinces of Zambia were reclassified as low-risk areas for yellow fever (YF). However, the current potential for YF transmission in these areas is unclear. Aims: To determine the ... -
Risk estimation of the SARS-CoV-2 acute respiratory disease outbreak outside China
(2020-06-05)Background: On December 31, 2019, the World Health Organization was alerted to the occurrence of cases of pneumonia in Wuhan, Hubei Province, China, that were caused by an unknown virus, which was later identified as a ...